Boston Baskin Cancer Foundation

Memphis, Tennessee 38120

0 studies enrolling now · 3 studies all time

What they study most

Prostatic Neoplasms, Solid Tumor, Unresectable or Metastatic Hepatocellular Carcinoma

Studies at this site

• Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-resistant Prostate Cancer — Completed
• A Trial Of CVX-060, An Anti-Angiogenic COVX-Body, In Combination With Sunitinib In Patients With Advanced Renal Cell Carcinoma — Stopped early
• Temsirolimus as Second-line Therapy in HCC — Status unconfirmed